This ELISA has been extensively evaluated in various NAFLD studies demonstrating that caspase-cleaved K18 fragments (M30 levels) are significantly increased in sera from NASH compared to NAFL patients [12,13,14,15]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.